Your browser doesn't support javascript.
loading
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries.
Malinowski, Krzysztof Piotr; Kawalec, Pawel; Trabka, Wojciech; Czech, Marcin; Petrova, Guenka; Manova, Manoela; Savova, Alexandra; Draganic, Pero; Vostalová, Lenka; Slabý, Juraj; Männik, Agnes; Márky, Kristóf; Rugaja, Zinta; Gulbinovic, Jolanta; Tesar, Tomas; Paveliu, Marian Sorin.
Afiliación
  • Malinowski KP; Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
  • Kawalec P; Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
  • Trabka W; Bioinformatics and Public Health Department, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland.
  • Czech M; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland.
  • Petrova G; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Manova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Savova A; National Council on Prices and Reimbursement of Medicinal Products, Sofia, Bulgaria.
  • Draganic P; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Vostalová L; National Council on Prices and Reimbursement of Medicinal Products, Sofia, Bulgaria.
  • Slabý J; Agency for Medicinal Products and Medical Devices of Croatia, Zagreb, Croatia.
  • Männik A; Department of Biotechnology, University of Rijeka, Rijeka, Croatia.
  • Márky K; Pricing and Reimbursement Regulation Branch, State Institute for Drug Control, Prague, Czechia.
  • Rugaja Z; Pricing and Reimbursement Regulation Branch, State Institute for Drug Control, Prague, Czechia.
  • Gulbinovic J; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
  • Tesar T; National Institute of Health Insurance Fund Management, Budapest, Hungary.
  • Paveliu MS; The National Health Service, Riga, Latvia.
Front Pharmacol ; 10: 487, 2019.
Article en En | MEDLINE | ID: mdl-31139080

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Health_technology_assessment / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Health_technology_assessment / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Polonia